Our role in beating cancer globally
Donate to us
Cancer is a global problem that needs global solutions. By donating today, you can fund our life-saving research and help beat cancer sooner.
Who are we?
Cancer affects people all over the world. To beat it, we need to work together.
Cancer Research UK is the largest independent funder of cancer research in the world. We support the best scientists, doctors and nurses to discover new ways to prevent, diagnose and treat cancer across the world. And we rely entirely on donations to make it happen.
- We bring together the world's best scientists to tackle cancer.
- We partner with organisations in every part of the world.
- We develop cancer drugs and other treatments that are used world-wide.
- We provide cancer information verified by doctors, nurses and other experts.
Since 1902 we’ve been funding cancer research through research institutes, centres and top universities including Oxford and Cambridge. Seven of our scientists have received Nobel Prizes for their research. Our discoveries have impacted people around the world, as we pioneered both radiotherapy and chemotherapy.
Our 4,000 scientists, doctors and nurses are working to bring forward the day when all cancers are cured.
Our scientists pioneer early radioatherapy - a cornerstone treatment saving thousands of lives and alleviating suffering today.
Our researchers discover chemicals that lead to the development of chemotherapy drugs. They are used to treat some cancers today.
Our researchers lead the development of the drug temozolomide, which is used to treat the most common adult brain tumour.
The Francis Crick Institute opens. Discoveries here will lead to new ways to diagnose and treat cancer across the world.
We provide $87million of funding to four international teams to tackle the Grand Challenges in cancer research.
“Without cancer research, I wouldn’t be here – it saves lives. What Cancer Research UK does is allowing me to watch my children grow up. Thank you to everyone who supports them.”
- Amanda Adams.
What makes us unique?
Bringing international scientists together
We offer US$25 million of funding to ambitious international teams of scientists and doctors tackling the hardest questions in cancer research.
Working across five continents
Together with our partners we fund research in five continents.
Launching trials for rare cancers
We make trials possible for people with rare cancers by working across borders: research that could not happen without international collaboration.
Tackling tobacco globally
We created PROACTT with the American Cancer Society, helping to protect people in less developed countries from the threat of tobacco.
Funding international clinical trials
We support ambitious international clinical trials, including working with a partner in India to study whether aspirin could stop cancer returning